Institute of Cancer Research (ICR)

The Institute of Cancer Research (the ICR) is a public research institute and university located in London, United Kingdom specialised in oncology, and a constituent college of the University of London.

A prototype AI test that can predict which drug combinations are likely to work for cancer patients in as little as 24 to 48 hours

Precision cancer drugs boost the immune system and help more patients benefit from immunotherapy

Precision cancer drugs called PARP inhibitors have a previously unknown ability to boost the immune system, and could help many more patients benefit from immunotherapy, a new study reveals. Scientists found that PARP inhibitors sparked a powerful immune response when used against cancer cells with weaknesses in repairing their DNA. The study changes our understanding

Precision cancer drugs boost the immune system and help more patients benefit from immunotherapy

World first as viral immunotherapy for skin cancer shows patient benefit in Phase III trial

A genetically engineered herpes virus can halt the progression of skin cancer by killing cancer cells and sparking the immune system into action against tumours, a landmark clinical trial has shown. It is the first time that a Phase III trial of viral immunotherapy has definitively shown benefit for patients with cancer. The trial was

World first as viral immunotherapy for skin cancer shows patient benefit in Phase III trial

Computer-controlled table could direct radiotherapy to tumours

Swivelling patients around on a computer-controlled, rotating table could deliver high doses of radiotherapy to tumours more quickly than current methods, while sparing vulnerable organs such as the heart, brain, eyes and bowel. Swivelling patients around on a computer-controlled, rotating table could deliver high doses of radiotherapy to tumours more quickly than current methods, while

Computer-controlled table could direct radiotherapy to tumours

Golden age of prostate cancer treatment hailed as fourth drug in two years extends life

A new drug can significantly extend life The head of one of the UK’s leading cancer research organisations has hailed a golden age in prostate cancer drug discovery as for the fourth time in two years results are published finding a new drug can significantly extend life. A study in the New England Journal of

Golden age of prostate cancer treatment hailed as fourth drug in two years extends life

Antidepressant Shows Promise as Cancer Treatment

Retinoids have already transformed one rare type of fatal leukemia into a curable disease An antidepressant combined with a drug derived from vitamin A could be used to treat a common adult form of leukemia, according to laboratory research led by a team at The Institute of Cancer Research (ICR). A retinoid called all-trans retinoic

Antidepressant Shows Promise as Cancer Treatment

The Latest Bing News on:
Institute of Cancer Research (ICR) Research
The Latest Bing News on:
Institute of Cancer Research (ICR) Discovery
What's Your Reaction?
Don't Like it!
0
I Like it!
0
View Comments (0)

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Scroll To Top